Advertisement
Advertisement
U.S. markets close in 1 hour 49 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Tilray, Inc. (TLRY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
11.54-0.05 (-0.43%)
As of 2:11PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Short-term KST

Short-term KST

Previous Close11.59
Open11.45
Bid11.51 x 800
Ask11.52 x 2900
Day's Range11.45 - 12.16
52 Week Range5.25 - 67.00
Volume24,662,595
Avg. Volume19,130,250
Market Cap5.347B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.17
Earnings DateNov 08, 2021 - Nov 12, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.95
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for TLRY

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Tilray, Inc. - Class 2
    Analyst Report: Tilray, Inc.Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
    Rating
    Fair Value
    Economic Moat
    13 days agoMorningstar
View more
  • Motley Fool

    Why Sundial, Tilray, and OrganiGram Stocks Are Glowing Green Today

    Today's gains probably shouldn't be too surprising, however, coming as they do on the back of positive comments from the CEO of MJBiz, a cannabis industry news site, yesterday evening. Speaking at MJBizCon 2021 in Las Vegas, company CEO Chris Walsh predicted that whatever happens in Congress, 2022 will see at least four more states flip to recreational marijuana legalization -- and perhaps as many as seven. Additionally, Walsh points out that Idaho and Nebraska are in line to legalize marijuana for medicinal purposes.

  • Motley Fool

    Could Another Acquisition Be on the Horizon for Tilray?

    The company's merger with Aphria closed in May, but investors shouldn't rule out another one in the near future.

  • Motley Fool

    Cannabis Producers Could Be Making a Colossal Mistake in Dismissing This Threat

    It has now been three full years since Canada legalized the recreational marijuana market on Oct. 17, 2018. In the early stages, marijuana producers in the country were generating strong growth numbers due to the new segment of the market opening up (previously, only medical marijuana had been legal). When cannabis producer Hexo reported its third-quarter earnings (for the period ending April 30) in June, its revenue of 22.7 million Canadian dollars was down 31% from the second quarter, in which sales were CA$32.9 million.

Advertisement
Advertisement